Working...
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02939651
Brief Title: A Study of Pembrolizumab in Patients With Neuroendocrine Tumors

First Submitted : October 3, 2016
First Submitted that Met QC Criteria : October 18, 2016
First Posted : October 20, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : June 25, 2019
Last Update Posted : June 27, 2019